Financhill
Back

Biodexa Pharmaceuticals Plc Vs. PTC Therapeutics Industry Stock Comparison

Sell
42

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
0.91
Seasonality Move:
-1.3%
Sell
40

PTCT
PTC Therapeutics

Last Price:
31.01
Seasonality Move:
8.11%
Sell
42
Biodexa Pharmaceuticals Plc (BDRX) is a Sell

Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?

  • The current Biodexa Pharmaceuticals Plc [BDRX] share price is $0.89. The Score for BDRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $31.17. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BDRX Stock Price Chart

What is Biodexa Pharmaceuticals Plc's stock price today?

  • The Biodexa Pharmaceuticals Plc share price today is $0.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing slight buying pressure.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $31.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.

BDRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 44.61 Sell
Chaikin Money Flow: 42635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.91 - 1.03) Sell
Bollinger Bands (100): (0.88 - 1.4) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 37.27 Sell
Chaikin Money Flow: 51415 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34 - 37.72) Sell
Bollinger Bands (100): (26.7 - 35.2) Buy

BDRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.92 Sell
20-day SMA: 0.96 Sell
50-day SMA: 1.05 Sell
200-day SMA: 2.22 Sell
8-day EMA: 0.91 Sell
20-day EMA: 0.96 Sell
50-day EMA: 1.05 Sell
200-day EMA: 28.3 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.02 Sell
20-day SMA: 35.78 Sell
50-day SMA: 33.9 Sell
200-day SMA: 27.61 Buy
8-day EMA: 33.59 Sell
20-day EMA: 34.77 Sell
50-day EMA: 33.84 Sell
200-day EMA: 31.82 Sell

Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.

Biodexa Pharmaceuticals Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):